Metoclopramide (Reglan): Works by speeding up gastric emptying, which can counteract the slowing effect of semaglutide
Indian companies are also developing a biosimilar for semaglutide where it seems that the patent will not be respected after 2026
We will begin with an amuse-bouche of GI physiology, incretin biology and diabetes
Vildagliptin The first clinical study with a DPP-4 inhibitor which eventually entered the market was presented in 2004
Although motor dysfunction is the core and defining feature of CP, the disorder is often accompanied by comorbidities, including epilepsy, intellectual disabilities, orthopedic complications, speech and vision impairments, and GI disturbances [253]
Community sources also commonly describe annual full-body dermatologic exams as the appropriate monitoring response though many users don't do them